New Key Statistics Module, Z-Score and F-Score
TSX:SZLS Key Ratios
Market Cap C$ M | 4.94 |
Enterprise Value C$ M | 7.35 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.74 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 2.00 |
EPS (TTM) C$ | -0.02 |
Beneish M-Score | -42.04 |
10-y EBITDA Growth Rate % | 27.60 |
5-y EBITDA Growth Rate % | 8.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.78 |
EV-to-EBITDA | -4.11 |
PEG | -- |
Shares Outstanding M | 123.55 |
Net Margin (%) | -78.30 |
Operating Margin % | -91.98 |
Pre-tax Margin (%) | -78.30 |
Quick Ratio | 0.02 |
Current Ratio | 0.02 |
ROA % (ttm) | -272.88 |
ROE % (ttm) | -- |
ROIC % (ttm) | -132.21 |
Dividend Yield % | -- |
Altman Z-Score | -517.81 |
TSX:SZLS Number of Guru Trades
TSX:SZLS Volume of Guru Trades
Gurus Latest Trades with TSX:SZLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:SZLS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
StageZero Life Sciences Ltd Insider Transactions
No Available Data